ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,297.10
-0.21%
US Tech 100
18,077.20
-0.21%
다우존스 지수
39,869.38
-0.10%
Bitcoin
65,305.14
-1.44%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Adaptive Biotechnologies Corporation (ADPT)

  7. Adaptive Biotechnologies Corporation (ADPT) 뉴스

ADPT

Adaptive Biotechnologies (ADPT)

Adaptive Biotechnologies Corporation
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:ADPT
일자시간출처헤드라인심볼기업
2024/05/0805:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ADPTAdaptive Biotechnologies Corporation
2024/05/0805:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADPTAdaptive Biotechnologies Corporation
2024/05/0805:05GlobeNewswire Inc.Adaptive Biotechnologies Reports First Quarter 2024 Financial ResultsNASDAQ:ADPTAdaptive Biotechnologies Corporation
2024/04/1805:05GlobeNewswire Inc.Adaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024NASDAQ:ADPTAdaptive Biotechnologies Corporation
2024/04/0305:05GlobeNewswire Inc.Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 RevenueNASDAQ:ADPTAdaptive Biotechnologies Corporation
2024/03/2721:30GlobeNewswire Inc.Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024NASDAQ:ADPTAdaptive Biotechnologies Corporation
2024/03/0709:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADPTAdaptive Biotechnologies Corporation
2024/03/0709:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADPTAdaptive Biotechnologies Corporation
2024/03/0709:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADPTAdaptive Biotechnologies Corporation
2024/03/0709:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADPTAdaptive Biotechnologies Corporation
2024/03/0709:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADPTAdaptive Biotechnologies Corporation
2024/03/0709:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADPTAdaptive Biotechnologies Corporation
2024/03/0709:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADPTAdaptive Biotechnologies Corporation
2024/03/0709:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADPTAdaptive Biotechnologies Corporation
2024/03/0709:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADPTAdaptive Biotechnologies Corporation
2024/03/0709:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADPTAdaptive Biotechnologies Corporation
2024/03/0709:38Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ADPTAdaptive Biotechnologies Corporation
2024/02/2306:05GlobeNewswire Inc.Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare ConferenceNASDAQ:ADPTAdaptive Biotechnologies Corporation
2024/02/1506:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADPTAdaptive Biotechnologies Corporation
2024/02/1506:05GlobeNewswire Inc.Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:ADPTAdaptive Biotechnologies Corporation
2024/01/3006:05GlobeNewswire Inc.Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 14, 2024NASDAQ:ADPTAdaptive Biotechnologies Corporation
2024/01/3006:00Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ADPTAdaptive Biotechnologies Corporation
2023/12/2806:05GlobeNewswire Inc.Adaptive Biotechnologies to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:ADPTAdaptive Biotechnologies Corporation
2023/12/0922:30GlobeNewswire Inc.Adaptive Biotechnologies Announces New Data Highlighting the Clinical Relevance of MRD Testing with clonoSEQ® in Patients with Blood Cancers at the 65th ASH Annual MeetingNASDAQ:ADPTAdaptive Biotechnologies Corporation
2023/12/0521:30GlobeNewswire Inc.Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts Demonstrating the Actionability of clonoSEQ® MRD Testing in Blood Cancer Patient Care and Drug Development at the 65th ASH Annual MeetingNASDAQ:ADPTAdaptive Biotechnologies Corporation
2023/11/2107:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADPTAdaptive Biotechnologies Corporation
2023/11/1006:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADPTAdaptive Biotechnologies Corporation
2023/11/1006:05GlobeNewswire Inc.Adaptive Biotechnologies Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ADPTAdaptive Biotechnologies Corporation
2023/11/0721:30GlobeNewswire Inc.Adaptive Biotechnologies Announces New Translational Collaboration to Measure Minimal Residual Disease with clonoSEQ® Assay Across BeiGene’s Lymphoid Malignancy PipelineNASDAQ:ADPTAdaptive Biotechnologies Corporation
2023/11/0305:05GlobeNewswire Inc.Adaptive Biotechnologies to Report Third Quarter Financial Results on November 9, 2023NASDAQ:ADPTAdaptive Biotechnologies Corporation
 검색 관련기사 보기:NASDAQ:ADPT

최근 히스토리

NASDAQ
AMZN
Amazon.com
FX
USDGBP
US Dollar vs Sterling
USOTC
RHHBY
Roche (QX)
NYSE
XOM
Exxon Mobil
AMEX
XLV
Health Care Select Sector
NYSE
BAC
Bank of America
USOTC
BNPQY
BNP Paribas (QX)
CCOM
US500
US 500
COIN
ETHUSD
Ethereum
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
KO
Coca Cola
COIN
BTCUSD
Bitcoin
NYSE
AXP
American Express
NYSE
DIS
Walt Disney
FX
USDEUR
US Dollar vs Euro
USOTC
BASFY
BASF (QX)
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유